A multivalent minigene vaccine, containing B-cell, cytotoxic T- lymphocyte, and T(h) epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen

Journal of Virology

Volumn 71, Issue 3, 1997, Pages 2292-2302

  An, Ling Ling ^a   Whitton, J Lindsay ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; INTERLEUKIN 2; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HELA CELL; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SENDAI VIRUS; T LYMPHOCYTE; VACCINATION; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT;

EID: 0031041585     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.3.2292-2302.1997     Document Type: Article

References (42)

1. Ahmed, R. 1992. Immunological memory against viruses. Semin. Immunol. 4:105-109.
2. Aichele, P., H. Hengartner, R. M. Zinkernagel, and M. Schulz. 1990. Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J. Exp. Med. 171:1815-1820.
3. Aichinger, G., and R. I. Lechler. 1995. Endogenous pathway of class II presentation. Biochem. Soc. Trans. 23:657-660.
4. An, L. L., E. G. Pamer, and J. L. Whitton. 1996. A recombinant minigene vaccine containing a nonameric cytotoxic-T-lymphocyte epitope confers limited protection against Listeria monocytogenes infection. Infect. Immun. 64: 1685-1693.
5. Bertoletti, A., A. Sette, F. V. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407-410.
6. Brooks, A. G., and J. McCluskey. 1993. Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells. J. Immunol. 150:3690-3697.
7. Burkhart, C., G. Freer, R. Castro, L. Adorini, K. H. Wiesmuller, R. M. Zinkernagel, and H. Hengartner. 1994. Characterization of T-helper epi-topes of the glycoprotein of vesicular stomatitis virus. J. Virol. 68:1573-1580.
8. Chimini, G., P. Pala, J. Sire, B. R. Jordan, and J. L. Maryanski. 1989. Recognition of oligonucleotide-encoded T cell epitopes introduced into a gene unrelated to the original antigen. J. Exp. Med. 169:297-302.
9. Cole, G. A., T. L. Hogg, and D. L. Woodland. 1994. The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells. Int. Immunol. 6:1767-1775.
10. Coligan, J., et al. 1995. Current protocols in immunology, unit 3.2. John Wiley & Sons, New York, N.Y.
11. del Val, M., H. J. Schlicht, T. Ruppert, M. J. Reddehase, and U. H. Koszinowski. 1991. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66:1145-1153.
12. Deres, K., T. N. Schumacher, K. H. Wiesmuller, S. Stevanovic, G. Greiner, G. Jung, and H. L. Ploegh. 1992. Preferred size of peptides that bind to H-2 Kb is sequence dependent. Eur. J. Immunol. 22:1603-1608.
13. Dick, L. R., C. Aldrich, S. C. Jameson, C. R. Moomaw, B. C. Pramanik, C. K. Doyle, G. N. DeMartino, M. J. Bevan, J. M. Forman, and C. A. Slaughter. 1994. Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides. J. Immunol. 152:3884-3894.
14. Driscoll, J., M. G. Brown, D. Finley, and J. J. Monaco. 1993. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365:262-264.
15. Dutko, F. J., and M. B. A. Oldstone. 1983. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64:1689-1698.
16. Eggers, M., B. Boes-Fabian, T. Ruppert, P. M. Kloetzel, and U. H. Koszinowski. 1995. The cleavage preference of the proteasome governs the yield of antigenic peptides. J. Exp. Med. 182:1865-1870.
17. Eisenlohr, L. C., J. W. Yewdell, and J. R. Bennink. 1992. Flanking sequences influence the presentation of an endogenously synthesised peptide to cytotoxic T lymphocytes, J. Exp. Med. 175:481-487.
18. Groettrup, M., A. Soza, M. Eggers, L. Kuehn, T. P. Dick, H. Schild, H. G. Rammensee, U. H. Koszinowski, and P. Kloetzel. 1996. A role for the proteasome regulator PA28a in antigen presentation. Nature 381:166-168.
19. Hahn, Y. S., C. S. Hahn, V. L. Braciale, T. J. Braciale, and C. M. Rice. 1992. CDS+ T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope. J. Exp. Med. 176:335-1341.
20. Henderson, R. A., H. Michel, K. Sakaguchi, J. Shabanowitz, E. Appella, D. F. Hunt, and V. H. Engelhard. 1992. HLA2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science. 255:1264-1266.
21. Klavinskis, L. S., J. L. Whitton, E. Joly, and M. B. A. Oldstone. 1990. Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology 178:393-400.
22. Klavinskis, L. S., J. L. Whitton, and M. B. A. Oldstone. 1989. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection. J. Virol. 63:4311-4316.
23. Kulkarni, A. B., P. L. Collins, I. Bacik, J. W. Yewdell, J. R. Bennink, J. E. Crowe, and B. R. Murphy. 1995. Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. J. Virol. 69:1261-1264.
24. Lanzavecchia, A. 1986. Antigen presentation by B lymphocytes: a critical step in T-B collaboration. Curr. Top. Microbiol. Immunol. 130:65-78.
25. Muir, S., J. P. Weintraub, J. Hogle, and J. L. Bittle. 1991. Neutralizing antibody to Mengo virus, induced by synthetic peptides. J. Gen. Virol. 72: 1087-1092.
26. Oldstone, M. B. A., A. Tishon, M. Eddleston, J. C. De La Torre, T. A. McKee, and J. L. Whitton. 1993. Vaccination to prevent persistent viral infection. J. Virol. 67:4372-4378.
27. Palmert, M. R., T. E. Golde, M. L. Cohen, D. M. Kovacs, R. E. Tanzi, J. F. Gusella, M. F. Usiak, L. H. Younkin, and S. G. Younkin. 1988. Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease. Science 241:1080-1084.
28. Schulz, M., P. Aichele, M. Vollenweider, F. W. Bobe, F. Cardinaux, H. Hengartner, and R. M. Zinkernagel. 1989. Major histocompatibility complex-dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease. Eur. J. Immunol. 19:1657-1668.
29. Selin, L. K., S. R. Nahill, and R. M. Welsh. 1994. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 179:1933-1943.
30. Sheng, N., J, Zhang, T. A. McKee, and J. L. Whitton. 1993. A rapid and simple method for determining the DNA sequences of fragments inserted into recombinant vaccinia viruses. BioTechniques 14:781-784.
31. Thomson, S. A., S. L. Elliott, M. A. Sherritt, K. W. Sproat, B. E. Coupar, A. A. Scalzo, C. A. Forbes, A. M. Ladhams, X. Y. Mo, R. A. Tripp, P. C. Doherty, D. J. Moss, and A. Suhrbier. 1996. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes. J. Immunol. 157:822-826.
32. Thomson, S. A., R. Khanna, J. Gardner, S. R. Burrows, B. Coupar, D. J. Moss, and A. Suhrbier, 1995. Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8 + cytotoxic T cells implications-for vaccine design. Proc. Natl. Acad. Sci. USA 92:5845-5849.
33. Villanueva, M. S., P. Fischer, K. Feen, and E. G. Pamer. 1994. Efficiency of MHC class I antigen processing: a quantitative analysis. Immunity 1:479-489.
34. Vordermeier, H. M., D. P. Harris, C. Moreno, and J. Ivanyi. 1994. Promiscuous T cell recognition of an H-2 IA-presented mycobacterial epitope. Eur. J. Immunol. 24:2061-2067.
35. Wei, M. L., and P. Cresswell. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356:443-446.
36. Whitton, J. L. 1994. Induction of protective immunity using minigenes. Ann. N. Y. Acad. Sci. 730:107-117.
37. Whitton, J. L., J. R. Gebhard, H. Lewicki, A. Tishon, and M. B. A. Oldstone. 1988. Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 62:687-695.
38. Whitton, J. L., and M. B. A. Oldstone. 1996. The immune response of viruses, p. 345-374. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields' virology, 3rd ed. Raven Press, New York, N.Y.
39. Whitton, J. L., M. B. A. Oldstone, and M. B. Oldstone. 1989. Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes. J. Exp. Med. 170:1033-1038.
40. Whitton, J. L., N. Sheng, M. B. A. Oldstone, and T. A. McKee. 1993. A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J. Virol. 67:348-352.
41. Whitton, J. L., A. Tishon, H. Lewicki, J. R. Gebhard, T. Cook, M. S. Salvato, E. Joly, and M. B. A. Oldstone. 1989. Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J. Virol. 63:4303-4310.
42. Yokoyama, M., J. Zhang, and J. L. Whitton. 1995. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69:2684-2688.